Cognitive Functions in Severe Dementia

Severe Dementia

Volumn , Issue , 2006, Pages 41-49

  Saxton, Judith ^a   Boller, François ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CENTRE PAUL BROCA   (France)

Author keywords

Autobiographic memory loss; Cognitive impairment; Praxis and visuospatial ability impairment; Severe dementia assessment tools; Severe impairment battery (SIB)

Indexed keywords

EID: 84889320419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470010568.ch4     Document Type: Chapter

References (37)

1. Albert M, Cohen C (1992) The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. Journal of the American Geriatric Society, 40:449-453.
2. Auer S, Reisberg B (1996) Reliability of the Modified Ordinal Scales of Psychological Development: a cognitive assessment battery for severe dementia. International Psychogeriatrics, 8(2):225-231.
3. Auer S, Sclan S, Yaffee Y, Reisberg B (1994) The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia. Journal of the American Geriatric Society, 42:1266-1272.
4. Barbarotto R, Cerri M, Acerbi C, Molinari S, Capitani E (2000) Is SIB or BNP better than MMSE in discriminating the cognitive performance of severely impaired elderly patients? Archives of Clinical Neuropsychology, 15(1):21-29.
5. Boller F, Holland A, Forbes M, Hood P, McGonigle-Gibson K, Becker JT, (1991) Predictors of decline in Alzheimer's disease. Cortex, 27:9-17.
6. Boller F, Verny M, Hugonot-Diener L, Saxton J (2002) Clinical features and assessment of severe dementia: a review. European Journal of Neurology, 9(2):125-136.
7. Boller F, Saxton J, Kastengo KB, et al. (2004) Short version of the severe impairment battery (SIB). Neurology, 62 Suppl 5:A131-132.
8. Dartigues J, Helmer C, Letenneur L (2002) Epidemiologie des demences, in Les Demences. Edited by Duychaerts C, Pasquier F. Paris: Douin, pp 5-13.
9. Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E (2001) A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology, 57(4):613-620.
10. Foldi NS, Majerovitz SD, Sheikh K, Rodriguez E (1999) The test for severe impairment: validity with the dementia rating scale and utility as a longitudinal measure. Clinical Neuropsychologist, 13(1):22-29.
11. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12:189-198.
12. Fratiglioni L, Aguero-Torres H, Winblad B (1994) The impact of dementia on our societies and current possibilities of prevention. International Journal of Geriatric Psychopharmacology, 1:179-183.
13. Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P (2002) Functional cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease. Current Medical Research and Design, 18(6):347-354.
14. Han L, Cole M, Bellavance F, McCusker J, Primeau F, (2000) Tracking cognitive decline in Alzheimer's disease using the Mini Mental State Examination: a meta-analysis. International Psychogeriatrics, 12(2):231-247.
15. Harrell LE, Marson D, Chatterjee A, Parrish JA (2000) The Severe Mini-Mental State Examination: a new neuropsychologic instrument for the bedside assessment of severely impaired patients with Alzheimer disease. Alzheimer Disease and Associated Disorders: An International Journal, 14(3):168-175.
16. Hughes, C.B., Berg L, Danziger WL (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140:566-572.
17. Jacobs D, Albert SM, Sano M, del Castillo-Castaneda C, Paik M, Marder K, Bell K, Brandt J, Albert MS, Stern Y (1999) Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52(8):1689-1691.
18. Katzman R, Brown T, Thal LJ, et al. (1988) Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology, 24:384-389.
19. Mattis S (1988) Dementia rating scale (DRS). Odessa FL: Psychological Assessment Resources.
20. Panisett M, Roudier M, Saxton J, Boller F (1994) Severe Impairment Battery: a neuropsychological test for severely demented patients. Archives of Neurology, 51:41-45.
21. Peavy GM, Salmon DP, Rice VA, et al. (1996) Neuropsychological assessment of severely demented elderly: the severe cognitive impairment profile. Archives of Neurology, 53:367-372.
22. Pippi M, Mecocci P, Saxton J, Bartorelli L, Pettenati C, Bonaiuto S, Cucinotta D, Masaraki G, Neri M, Tammaro AE, Vergani C, Chionne F, Senin U (1999) Neuropsychological assessment of the severely impaired elderly patients: validation of the Italian short version of the Severe Impairment Battery (SIB). Aging, Clinical and Experimental Research, 11(4):221-226.
23. Reisberg B (1988) functional assessment staging (FAST). Psychopharmacology Bulletin, 653-659.
24. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139:1136-1139.
25. Reisberg B, Sclan G, Franzsen E, Klugger A, Ferris S (1994) Dementia staging in chronic care populations. Alzheimer disease and Related Disorders, 8(Suppl 1):5188-5205.
26. Reisberg B, Doody R, Stoffler A, et al. (2003) Memantine in moderate-to-severe Alzheimer's disease. The New England Journal of Medicine, 348:1333-1341.
27. Roudier M, Marcie P, Grancher AS, Starkstein S, Boller F (1998) Discrimination of facial indentity and of emotions in Alzhiemer's disease. Journal of Neurological Sciences, 154:151-158.
28. Saxton J, Swihart AA (1989) Neuropsychological assessment of the severely impaired elderly patient. Clinical Geriatric Medicine, 5:531-543.
29. Saxton J, McGonigle-Gibson K, Swihart A, Miller M, Boller F (1990) Assessment of the severely impaired patient: description and validation of a new neuropsychological test battery. Psychological Assessment, 2:298-303.
30. Schmitt FA, Ashford JW, Ferris S, et al. (1996) Severe Impairment Battery: a potential measure for AD clinical trials, in Alzheimer Disease: From Molecular Biology to Therapy. Edited by Becker R, Giacobini E. Boston, Birkhauser, pp 419-423.
31. Schmitt FA, Ashford W, Ernesto C, Saxton J, et al. (1997) The Severe Impairment Battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheimer Disease and Associated Disorders, 11:S51-S56.
32. Tariot PN, Farlow MR, Grossberg GT, et al. (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. The Journal of the American Medical Association, 291, No.3:317-324.
33. Venneri A, Pentore R, Coticelli B, Della Salla S (1998) Unilateral spatial neglect in the late stage of Alzheimer's disease. Cortex, 34:743-752.
34. Verny M, Hugonot-Diener L, Saillon A, et al. (1999) Evaluation de la démence sévère: échelles cognitives et comportementales (groupe de travail du GRECO). L'année Gérontologica Serdi, 156-168.
35. Wild KV, Kaye JA (1997) The rate of progression of Alzheimer's disease in the later stages: Evidence from the severe impairment battery. Journal of the International Neuropsychological Society, 4:512-516.
36. Wild KV, Kaye JA (1998) Rate of progression in the later stages of Alzheimer disease: evidence from the severe impairment battery. Clinical Neuropsychologist, 12(2):281.
37. Wild KV, Howieson D, Lear J, Carrsyn C, Kay J (1993) Assessing the severely impaired dementia patient - functional correlates of the severe impairment battery. Journal of Clinical and Experimental Neuropsychology, 15(1):29.